Congress Weighs Repeal of Tax Credit for Rare Disease Drugs by KATIE THOMAS and SHEILA KAPLAN

This entry was posted in Health Weight Watchers and tagged Health NYT on by

Long untouchable, the incentive for development of orphan drugs is now a Republican target as lawmakers consider a broad tax overhaul.

Published: November 8, 2017 at 01:00AM

from NYT Health https://ift.tt/2zpkko8